Quintiles Phase One Clinical Trials India Private Limited - Company Profile

It is a healthcare foreign private limited company based in Hyderabad, Telangana, India, established in 2009.

2009 Hyderabad, Telangana, India Dissolved (Liquidated)

Last Updated: July 25, 2025

About Quintiles Phase One Clinical Trials India Private Limited

Quintiles Phase One Clinical Trials India Private Limited, a dissolved (liquidated) foreign private limited company, was established on 03 July 2009 in Hyderabad, Telangana, India. Engaging in preventive health services within the healthcare sector, it holds CIN: U73100TG2009FTC064239. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹38.00 Cr and a paid-up capital of ₹36.57 Cr.

It upholds a compliant status. Its leadership includes Nilanjan Sinha (Director), Arjun Aiyar (Director), Haripprasad Kovalamuri (Director). Past directors included Paul Francis Casey, Edward Caffrey, Nilanjan Sinha. Its latest AGM occurred on 29 June 2020, with the balance sheet filed on 31 March 2020. It is based at 7Th & 8Th Floor, Apollo Health Street Building, Apollo Health City, Behind Kbr Park, Jub, Ilee Hills, Hyderabad, Telangana, 500033.

Company Details

CIN/LLPIN
U73100TG2009FTC064239
Registration Number
064239
Incorporation Date
03 July 2009
Authorized Capital
₹38.00 Cr
Paid-Up Capital
₹36.57 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Dissolved (Liquidated)

Key Metrics

Authorised Capital ₹ 38.00 Cr as on 25-07-2025
Paid Up Capital ₹ 36.57 Cr as on 25-07-2025
Company Age 16 Year, 8 Months
Last Filing with ROC 31 Mar 2020
Revenue Growth **** -95.71% (FY 2016)
Profit Growth **** -170.66% (FY 2016)
Ebitda **** -266.59% (FY 2016)
Net Worth -51.44% (FY 2016)
Total Assets -1.51% (FY 2016)

Comprehensive Company Insights

Explore comprehensive insights into Quintiles Phase One Clinical Trials India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Quintiles Phase One Clinical Trials India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Nilanjan Sinha	Director	14 Nov 2016	Current
Arjun Aiyar	Director	01 Nov 2016	Current
Haripprasad Kovalamuri	Director	15 May 2013	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	17 Jun 2011	Past
Pramod Abcsdd	Director	17 Jun 2011	Past
Pramod Abcsdd	Additional Director	21 Sep 2017	Past
Pramod Abcsdd	Director	14 Nov 2016	Past
Pramod Abcsdd	Alternate Director	24 Mar 2011	Past
Pramod Abcsdd	Director	06 Jan 2016	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Quintiles Phase One Clinical Trials India.

Quintiles Phase One Clinical Trials India Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 95.71% decrease. The company also saw a substantial fall in profitability, with a 170.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 51.44%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-95.71%

*******

Revenue from Operations

*******

Total Assets

*******

-1.51%

*******

Profit or Loss

*******

-170.66%

*******

Net Worth

*******

-51.44%

*******

EBITDA

*******

-266.59%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Quintiles Phase One Clinical Trials India?

In 2017, Quintiles Phase One Clinical Trials India had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Quintiles Phase One Clinical Trials India?

Unlock and access historical data on people associated with Quintiles Phase One Clinical Trials India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Quintiles Phase One Clinical Trials India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quintiles Phase One Clinical Trials India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Quintiles Phase One Clinical Trials India

Recent Activity within the Organization

Annual General Meeting

The activity Quintiles Phase One Clinical Trials India Private Limited last Annual general meeting of members was held on 29 Jun 2020 as per latest MCA records. was completed.
29 Jun 2020
Balance Sheet

Progress on Quintiles Phase One Clinical Trials India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was documented.
31 Mar 2020
Director Appointment

Khusboo Singhvi was appointed as a Company Secretary was appointed as a Company Secretary on 24 Apr 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
24 Apr 2019
Director Appointment

Progress on Nilanjan Sinha was appointed as a Director was appointed as a Director on 14 Nov 2016 & has been associated with this company since 9 years 3 months . was documented.
14 Nov 2016
Director Appointment

Arjun Aiyar was appointed as a Director was appointed as a Director on 01 Nov 2016 & has been associated with this company since 9 years 4 months . was recorded as a recent event.
01 Nov 2016
Director Appointment

Progress on Haripprasad Kovalamuri was appointed as a Director was appointed as a Director on 15 May 2013 & has been associated with this company since 12 years 9 months . was documented.
15 May 2013

Explore recent activity and updates - View Recent Activity